This comprehensive report analyzes the global retinal screening software market, providing a detailed forecast from 2026 through 2032. The study examines critical technologies, including AI-based and traditional computer-aided diagnosis software, used to detect ophthalmic diseases like diabetic retinopathy and glaucoma. By evaluating key segments, regional developments across the Americas, APAC, and Europe, and competitive strategies of major players, the report identifies emerging growth opportunities and the evolving technological landscape within the medical and ophthalmology research sectors.

Executive Overview

The global Retinal Screening Software market is projected to experience significant growth from 2025 through 2032, expanding at a steady compound annual growth rate over the forecast period.

Retinal screening software is a specialized medical software application utilized for the detection and analysis of retinal images. It serves as a critical tool for clinicians to diagnose and monitor various ophthalmic diseases, including but not limited to:

• Diabetic retinopathy
• Macular degeneration
• Glaucoma

Typically, this software incorporates several core functions, including image capture, processing, analysis, and the generation of diagnostic reports.

Regional Market Outlook

Global Market

The global Retinal Screening Software market is anticipated to undergo substantial expansion between 2025 and 2032, maintaining a consistent growth trajectory.

United States

The United States market for Retinal Screening Software is estimated to increase significantly from 2025 through 2032, following a sustained compound annual growth rate.

China

The China market for Retinal Screening Software is expected to see marked growth from 2025 to 2032, characterized by a steady compound annual growth rate.

Europe

The Europe market for Retinal Screening Software is projected to expand throughout the forecast period from 2025 to 2032 at a consistent compound annual growth rate.

Market Segmentation

By Type

• AI-Based Software
• Traditional Computer-Aided Diagnosis Software
• Others

By Application

• Medical Industry
• Ophthalmology Research
• Others

By Geography

• Americas: United States, Canada, Mexico, Brazil
• APAC: China, Japan, Korea, Southeast Asia, India, Australia
• Europe: Germany, France, UK, Italy, Russia
• Middle East & Africa: Egypt, South Africa, Israel, Turkey, GCC Countries

Competitive Landscape

Key Market Dynamics

• Market Concentration: In 2025, the global market saw significant concentration, with the two largest companies holding a substantial portion of the total market share.
• Competitive Analysis: This report evaluates the strategies of leading global companies, focusing on their Retinal Screening Software portfolios and capabilities, market entry strategies, market positions, and geographic footprints to understand their unique standing in an accelerating market.
• Industry Trends: The analysis highlights key trends related to product segmentation, company formation, revenue, market share, latest developments, and M&A activity.

Key Players

The following companies have been profiled based on primary expert input and analysis of their market coverage, product portfolios, and market penetration:

• RETINA-AI Health
• IRIS
• Retina Labs
• CheckEye
• RetinaLyze
• NEC Software
• InHealth Intelligence
• RetinaRisk
• Thirona Retina
• Synapxe
• Eyenuk
• EyRIS (SELENA+)
• Vistel

About the Report

Produced by LPI (LP Information), the “Retinal Screening Software Industry Forecast” provides a comprehensive analysis of past sales and reviews total world Retinal Screening Software sales in 2025. The report offers a detailed analysis of projected sales for 2026 through 2032, broken down by region, market sector, and sub-sector, presented in US$ millions.

This Insight Report evaluates key market trends, drivers, and affecting factors shaping the global outlook. It utilizes a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs to provide a nuanced view of the current state and future trajectory of the global Retinal Screening Software industry, highlighting emerging pockets of opportunity across various segments.

• 1 Scope of the Report

  • 1.1 Market Introduction

  • 1.2 Years Considered

  • 1.3 Research Objectives

  • 1.4 Market Research Methodology

  • 1.5 Research Process and Data Source

  • 1.6 Economic Indicators

  • 1.7 Currency Considered

  • 1.8 Market Estimation Caveats

• 2 Executive Summary

  • 2.1 World Market Overview

    • 2.1.1 Global Retinal Screening Software Market Size (2021-2032)

    • 2.1.2 Retinal Screening Software Market Size CAGR by Region (2021 VS 2025 VS 2032)

    • 2.1.3 World Current & Future Analysis for Retinal Screening Software by Country/Region (2021, 2025 & 2032)

  • 2.2 Retinal Screening Software Segment by Type

    • 2.2.1 AI-Based Software

    • 2.2.2 Traditional Computer-Aided Diagnosis Software

    • 2.2.3 Others

    • 2.2.4 Retinal Screening Software Market Size by Type

      • 2.2.4.1 Retinal Screening Software Market Size CAGR by Type (2021 VS 2025 VS 2032)
      • 2.2.4.2 Global Retinal Screening Software Market Size Market Share by Type (2021-2026)

  • 2.3 Retinal Screening Software Segment by Application

    • 2.3.1 Medical Industry

    • 2.3.2 Ophthalmology Research

    • 2.3.3 Others

    • 2.3.4 Retinal Screening Software Market Size by Application

      • 2.3.4.1 Retinal Screening Software Market Size CAGR by Application (2021 VS 2025 VS 2032)
      • 2.3.4.2 Global Retinal Screening Software Market Size Market Share by Application (2021-2026)

• 3 Retinal Screening Software Market Size by Player

  • 3.1 Retinal Screening Software Market Size Market Share by Player

    • 3.1.1 Global Retinal Screening Software Revenue by Player (2021-2026)

    • 3.1.2 Global Retinal Screening Software Revenue Market Share by Player (2021-2026)

  • 3.2 Global Retinal Screening Software Key Players Head office and Products Offered

  • 3.3 Market Concentration Rate Analysis

    • 3.3.1 Competition Landscape Analysis

    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)

  • 3.4 New Products and Potential Entrants

  • 3.5 Mergers & Acquisitions, Expansion

• 4 Retinal Screening Software by Region

  • 4.1 Retinal Screening Software Market Size by Region (2021-2026)

  • 4.2 Global Retinal Screening Software Annual Revenue by Country/Region (2021-2026)

  • 4.3 Americas Retinal Screening Software Market Size Growth (2021-2026)

  • 4.4 APAC Retinal Screening Software Market Size Growth (2021-2026)

  • 4.5 Europe Retinal Screening Software Market Size Growth (2021-2026)

  • 4.6 Middle East & Africa Retinal Screening Software Market Size Growth (2021-2026)

• 5 Americas

  • 5.1 Americas Retinal Screening Software Market Size by Country (2021-2026)

  • 5.2 Americas Retinal Screening Software Market Size by Type (2021-2026)

  • 5.3 Americas Retinal Screening Software Market Size by Application (2021-2026)

  • 5.4 United States

  • 5.5 Canada

  • 5.6 Mexico

  • 5.7 Brazil

• 6 APAC

  • 6.1 APAC Retinal Screening Software Market Size by Region (2021-2026)

  • 6.2 APAC Retinal Screening Software Market Size by Type (2021-2026)

  • 6.3 APAC Retinal Screening Software Market Size by Application (2021-2026)

  • 6.4 China

  • 6.5 Japan

  • 6.6 South Korea

  • 6.7 Southeast Asia

  • 6.8 India

  • 6.9 Australia

• 7 Europe

  • 7.1 Europe Retinal Screening Software Market Size by Country (2021-2026)

  • 7.2 Europe Retinal Screening Software Market Size by Type (2021-2026)

  • 7.3 Europe Retinal Screening Software Market Size by Application (2021-2026)

  • 7.4 Germany

  • 7.5 France

  • 7.6 UK

  • 7.7 Italy

  • 7.8 Russia

• 8 Middle East & Africa

  • 8.1 Middle East & Africa Retinal Screening Software by Region (2021-2026)

  • 8.2 Middle East & Africa Retinal Screening Software Market Size by Type (2021-2026)

  • 8.3 Middle East & Africa Retinal Screening Software Market Size by Application (2021-2026)

  • 8.4 Egypt

  • 8.5 South Africa

  • 8.6 Israel

  • 8.7 Turkey

  • 8.8 GCC Countries

• 9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities

  • 9.2 Market Challenges & Risks

  • 9.3 Industry Trends

• 10 Global Retinal Screening Software Market Forecast

  • 10.1 Global Retinal Screening Software Forecast by Region (2027-2032)

    • 10.1.1 Global Retinal Screening Software Forecast by Region (2027-2032)

    • 10.1.2 Americas Retinal Screening Software Forecast

    • 10.1.3 APAC Retinal Screening Software Forecast

    • 10.1.4 Europe Retinal Screening Software Forecast

    • 10.1.5 Middle East & Africa Retinal Screening Software Forecast

  • 10.2 Americas Retinal Screening Software Forecast by Country (2027-2032)

    • 10.2.1 United States Market Retinal Screening Software Forecast

    • 10.2.2 Canada Market Retinal Screening Software Forecast

    • 10.2.3 Mexico Market Retinal Screening Software Forecast

    • 10.2.4 Brazil Market Retinal Screening Software Forecast

  • 10.3 APAC Retinal Screening Software Forecast by Region (2027-2032)

    • 10.3.1 China Retinal Screening Software Market Forecast

    • 10.3.2 Japan Market Retinal Screening Software Forecast

    • 10.3.3 Korea Market Retinal Screening Software Forecast

    • 10.3.4 Southeast Asia Market Retinal Screening Software Forecast

    • 10.3.5 India Market Retinal Screening Software Forecast

    • 10.3.6 Australia Market Retinal Screening Software Forecast

  • 10.4 Europe Retinal Screening Software Forecast by Country (2027-2032)

    • 10.4.1 Germany Market Retinal Screening Software Forecast

    • 10.4.2 France Market Retinal Screening Software Forecast

    • 10.4.3 UK Market Retinal Screening Software Forecast

    • 10.4.4 Italy Market Retinal Screening Software Forecast

    • 10.4.5 Russia Market Retinal Screening Software Forecast

  • 10.5 Middle East & Africa Retinal Screening Software Forecast by Region (2027-2032)

    • 10.5.1 Egypt Market Retinal Screening Software Forecast

    • 10.5.2 South Africa Market Retinal Screening Software Forecast

    • 10.5.3 Israel Market Retinal Screening Software Forecast

    • 10.5.4 Turkey Market Retinal Screening Software Forecast

  • 10.6 Global Retinal Screening Software Forecast by Type (2027-2032)

  • 10.7 Global Retinal Screening Software Forecast by Application (2027-2032)

    • 10.7.1 GCC Countries Market Retinal Screening Software Forecast

• 11 Key Players Analysis

  • 11.1 RETINA-AI Health

    • 11.1.1 RETINA-AI Health Company Information

    • 11.1.2 RETINA-AI Health Retinal Screening Software Product Offered

    • 11.1.3 RETINA-AI Health Retinal Screening Software Revenue, Gross Margin and Market Share (2021-2026)

    • 11.1.4 RETINA-AI Health Main Business Overview

    • 11.1.5 RETINA-AI Health Latest Developments

  • 11.2 IRIS

    • 11.2.1 IRIS Company Information

    • 11.2.2 IRIS Retinal Screening Software Product Offered

    • 11.2.3 IRIS Retinal Screening Software Revenue, Gross Margin and Market Share (2021-2026)

    • 11.2.4 IRIS Main Business Overview

    • 11.2.5 IRIS Latest Developments

  • 11.3 Retina Labs

    • 11.3.1 Retina Labs Company Information

    • 11.3.2 Retina Labs Retinal Screening Software Product Offered

    • 11.3.3 Retina Labs Retinal Screening Software Revenue, Gross Margin and Market Share (2021-2026)

    • 11.3.4 Retina Labs Main Business Overview

    • 11.3.5 Retina Labs Latest Developments

  • 11.4 CheckEye

    • 11.4.1 CheckEye Company Information

    • 11.4.2 CheckEye Retinal Screening Software Product Offered

    • 11.4.3 CheckEye Retinal Screening Software Revenue, Gross Margin and Market Share (2021-2026)

    • 11.4.4 CheckEye Main Business Overview

    • 11.4.5 CheckEye Latest Developments

  • 11.5 RetinaLyze

    • 11.5.1 RetinaLyze Company Information

    • 11.5.2 RetinaLyze Retinal Screening Software Product Offered

    • 11.5.3 RetinaLyze Retinal Screening Software Revenue, Gross Margin and Market Share (2021-2026)

    • 11.5.4 RetinaLyze Main Business Overview

    • 11.5.5 RetinaLyze Latest Developments

  • 11.6 NEC Software

    • 11.6.1 NEC Software Company Information

    • 11.6.2 NEC Software Retinal Screening Software Product Offered

    • 11.6.3 NEC Software Retinal Screening Software Revenue, Gross Margin and Market Share (2021-2026)

    • 11.6.4 NEC Software Main Business Overview

    • 11.6.5 NEC Software Latest Developments

  • 11.7 InHealth Intelligence

    • 11.7.1 InHealth Intelligence Company Information

    • 11.7.2 InHealth Intelligence Retinal Screening Software Product Offered

    • 11.7.3 InHealth Intelligence Retinal Screening Software Revenue, Gross Margin and Market Share (2021-2026)

    • 11.7.4 InHealth Intelligence Main Business Overview

    • 11.7.5 InHealth Intelligence Latest Developments

  • 11.8 RetinaRisk

    • 11.8.1 RetinaRisk Company Information

    • 11.8.2 RetinaRisk Retinal Screening Software Product Offered

    • 11.8.3 RetinaRisk Retinal Screening Software Revenue, Gross Margin and Market Share (2021-2026)

    • 11.8.4 RetinaRisk Main Business Overview

    • 11.8.5 RetinaRisk Latest Developments

  • 11.9 Thirona Retina

    • 11.9.1 Thirona Retina Company Information

    • 11.9.2 Thirona Retina Retinal Screening Software Product Offered

    • 11.9.3 Thirona Retina Retinal Screening Software Revenue, Gross Margin and Market Share (2021-2026)

    • 11.9.4 Thirona Retina Main Business Overview

    • 11.9.5 Thirona Retina Latest Developments

  • 11.10 Synapxe

    • 11.10.1 Synapxe Company Information

    • 11.10.2 Synapxe Retinal Screening Software Product Offered

    • 11.10.3 Synapxe Retinal Screening Software Revenue, Gross Margin and Market Share (2021-2026)

    • 11.10.4 Synapxe Main Business Overview

    • 11.10.5 Synapxe Latest Developments

  • 11.11 Eyenuk

    • 11.11.1 Eyenuk Company Information

    • 11.11.2 Eyenuk Retinal Screening Software Product Offered

    • 11.11.3 Eyenuk Retinal Screening Software Revenue, Gross Margin and Market Share (2021-2026)

    • 11.11.4 Eyenuk Main Business Overview

    • 11.11.5 Eyenuk Latest Developments

  • 11.12 EyRIS (SELENA+)

    • 11.12.1 EyRIS (SELENA+) Company Information

    • 11.12.2 EyRIS (SELENA+) Retinal Screening Software Product Offered

    • 11.12.3 EyRIS (SELENA+) Retinal Screening Software Revenue, Gross Margin and Market Share (2021-2026)

    • 11.12.4 EyRIS (SELENA+) Main Business Overview

    • 11.12.5 EyRIS (SELENA+) Latest Developments

  • 11.13 Vistel

    • 11.13.1 Vistel Company Information

    • 11.13.2 Vistel Retinal Screening Software Product Offered

    • 11.13.3 Vistel Retinal Screening Software Revenue, Gross Margin and Market Share (2021-2026)

    • 11.13.4 Vistel Main Business Overview

    • 11.13.5 Vistel Latest Developments

• 12 Research Findings and Conclusion